Akums Drugs And Pharmaceuticals: Board Meeting Intimation for Consideration And Approval Of Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 31St March 2025 And Audited (Standalone & Consolidated) Financial Statements For The Year Ended On 31St March 2025

Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Un-audited (Standalone & Consolidated) Financial Results for the quarter ended on 31st March 2025 and Audited (Standalone & Consolidated) Financial statements for the year ended on 31st March 2025